Profil
Ambarish Shah is Chief Technology Officer at DiaMedica Therapeutics, Inc. since 2023.
Formerly, Dr. Shah was Executive Director & Head-Drug Product Development at Bristol Myers Squibb Co. and Vice President & Head-Global Vaccines Development at Csl Seqirus.
Education includes a doctorate from Mercer University, a graduate degree from Duquesne University School of Law, and an undergraduate degree from the University of Mumbai.
Aktive Positionen von Ambarish Shah
| Unternehmen | Position | Beginn |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.09.2023 |
Ehemalige bekannte Positionen von Ambarish Shah
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Direktor/Vorstandsmitglied | - |
Csl Seqirus | Corporate Officer/Principal | - |
Ausbildung von Ambarish Shah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Mercer University
Mercer University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duquesne University School of Law
Duquesne University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Csl Seqirus | Health Technology |
















